Three Motley Fool contributors think they've found unstoppable dividend stocks to buy right now. Here's why they picked ...

Looking into the current session, Pfizer Inc. (PFE) shares are trading at $25.84, after a 0.39% increase. Moreover, over the ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

In the first half of 2025, Rinvoq generated sales of $3.7 billion, reflecting a 49% year-over-year increase. Rinvoq sales ...

Pfizer Inc faces a new challenge as Enanta Pharmaceuticals sues over a patent infringement concerning Paxlovid in the EU.

Achieve Life Sciences Inc. (NASDAQ:ACHV) is moving closer to a pivotal moment as it seeks FDA approval for cytisinicline, a ...

Enanta Pharmaceuticals has initiated legal action against Pfizer (PFE) over a patent infringement related to Paxlovid, ...

In terms of liquidity and interest, the mean open interest for Pfizer options trades today is 13596.29 with a total volume of 13,024.00. In the following chart, we are able to follow the development ...

Pfizer's (NYSE:PFE) stock is up by a considerable 10% over the past three months. We wonder if and what role the company's financials play in that price change as a company's long-term fundamentals ...

Bank of India (RBI) has invited public comments on the draft circular on Counterparty Credit Risk: Add-on factors for computation of Potential Future Exposure Revised Instructions. Extant instructions ...

Pfizer Inc. (PFE) recently updated investors on their ongoing Phase 3 clinical study, which could be a game-changer in lung ...

Pfizer (PFE) stock in focus as Enanta Pharmaceuticals (ENTA) sues the pharma giant in the EU, claiming its COVID pill ...